In a bid to spotlight groundbreaking healthcare startups, the organizers of the INVEST conference have launched an exciting competition called Pitch Perfect. Scheduled for May 20-21, 2025, at the iconic Willis Tower in Chicago, this event offers entrepreneurs the opportunity to showcase their innovations to a panel of seasoned investment professionals. The winning startup will not only gain valuable exposure through a featured profile but also receive a $20,000 branding advertising package from MedCity News. Applications are now open until January 24, 2025, with no entry fee required.

Pitch Perfect: A Platform for Healthcare Startups to Shine

The INVEST conference is set to host an exhilarating pitch contest aimed at identifying the most promising startups across four specialized tracks: biopharma, devices & diagnostics, health tech for consumer/employer solutions, and health tech for payer/provider applications. Each track will feature six finalists who will present their innovative solutions before an esteemed audience. The competition criteria emphasize startups that are relatively new to the market, with eligibility extending up to five years for most categories, or ten years for biopharma and device/diagnostic ventures. Notably, previous finalists within the last year are ineligible to reapply.

To participate, startups must register for the conference, which comes at a special rate of $695 for selected pitchers. The rigorous selection process will be overseen by investment professionals, with finalists announced in April 2025. This platform promises to bridge the gap between cutting-edge healthcare technology and potential investors, fostering growth and innovation in the industry.

From an observer's perspective, events like Pitch Perfect serve as vital catalysts for advancing healthcare solutions. They provide a unique opportunity for startups to gain visibility, secure funding, and ultimately contribute to improving patient outcomes. By highlighting these emerging companies, the healthcare ecosystem can thrive, driving forward the next wave of medical advancements.